{"result": "Cetilistat is a gastric and pancreatic lipase inhibitor that has been approved in Japan. It is similar to Orlistat, but it is noted for having fewer side effects. Cetilistat has been evaluated as a weight loss medication in a randomized, placebo-controlled trial specifically targeting its efficacy in obese diabetics.", "input": "\nYou are a helpful assistant responsible for generating a comprehensive summary of the data provided below.\nGiven one or two entities, and a list of descriptions, all related to the same entity or group of entities.\nPlease concatenate all of these into a single, comprehensive description. Make sure to include information collected from all the descriptions.\nIf the provided descriptions are contradictory, please resolve the contradictions and provide a single, coherent summary.\nMake sure it is written in third person, and include the entity names so we have the full context.\n\n#######\n-Data-\nEntities: \"CETILISTAT\"\nDescription List: [\"Cetilistat is a gastric and pancreatic lipase inhibitor approved in Japan, similar to Orlistat but with fewer side effects.\", \"Cetilistat is a weight loss medication evaluated in a randomized, placebo-controlled trial for its efficacy in obese diabetics.\"]\n#######\nOutput:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 500, "n": 1}, "history": null}